ADMA Biologics ADMA Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ADMA Biologics's operating lease right-of-use assets in other assets?
- ADMA Biologics (ADMA) reported operating lease right-of-use assets in other assets of $6.4M in Q1 2026.
- How has ADMA Biologics's operating lease right-of-use assets in other assets changed year-over-year?
- ADMA Biologics's operating lease right-of-use assets in other assets decreased by 20.2% year-over-year, from $8.02M to $6.4M.
- What is the long-term trend for ADMA Biologics's operating lease right-of-use assets in other assets?
- Over 5 years (2020 to 2025), ADMA Biologics's operating lease right-of-use assets in other assets has grown at a 9.3% compound annual growth rate (CAGR), from $4.26M to $6.65M.